Advertisement
In 2018

CDC: Uninsurance Levels Did Not Change Significantly in 2018

0
Uninsurance increased among adults aged 45 to 64 years; increase seen in high-deductible health plans
Nut intake during the first trimester of pregnancy is associated with long-term child neuropsychological development

Nut Intake in First Trimester May Benefit Child Neurodevelopment

0
Children of mothers with the highest level of nut intake have better scores on cognitive tests
In 2018

2018 Saw More Employed Physicians Than Self-Employed

0
Proportion of physicians working in practices wholly owned by physicians dropped to 54 percent in 2018
In response to public demands for action to control drug costs

Prices Will Soon Be Included in TV Drug Ads

0
Regulations will require companies to disclose prices of meds costing more than $35 for a month's supply
For patients with symptomatic pulmonary embolism

Patent Foramen Ovale Ups Ischemic Stroke in Those With PE

0
Frequency of ischemic stroke increased in association with patent foramen ovale in symptomatic PE
In 2015 to 2016

In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs

0
Prescription drug use increased with age, reaching 85.0 percent for those aged 60 years and older
The average price for single-source brand-name drugs is higher in the United States than in other countries

External Reference Pricing Could Cut Drug Costs in U.S.

0
Prices averaged 3.2 to 4.1 times higher in U.S.; differential varied from 1.3 to 70.1 for individual drugs
Efforts are needed to ensure all completed large trials are reported

Efforts Needed to Ensure Publication of All Trials

0
67 trials ID'd that were unreported for median of nine years after completion, with 87,883 participants
In a new American Academy of Neurology guideline published in the May 7 issue of Neurology

Recommendations Issued for Treating Tourette Syndrome

0
Guidelines based on systematic review, focus on individualized treatment decisions
Ruzurgi (amifampridine) tablets are now approved to treat Lambert-Eaton myasthenic syndrome in children aged 6 to 17 years

FDA Approves Ruzurgi for Children With Rare Autoimmune Disorder

0
Ruzurgi previously approved for treatment in adults with Lambert-Eaton myasthenic syndrome